✦ 24h Briefing Top Stories World U.S.India Business Technology Science Health Sports Entertainment

Loading

Fetching the latest headlines…

NabkaNews aggregates headlines from thousands of publishers worldwide via Google News, and provides AI-generated summaries and briefings for convenience. Every story links to its original source. We do not host or claim ownership of third-party reporting, and AI summaries may contain errors — always verify with the original source.

24h Briefing Top Stories World U.S.India Business Technology Science Health Sports Entertainment

Disclaimer Privacy Policy Terms of Use

© 2026 NabkaNews · World · U.S. · India — updated continuously. NabkaNews is an independent news aggregator and is not affiliated with any publisher shown.

Q4 Earnings Highs And Lows: Pfizer (NYSE:PFE) Vs The Rest Of The Branded Pharmaceuticals Stocks · NabkaNews

← Back to headlines

Illustrative

Q4 Earnings Highs And Lows: Pfizer (NYSE:PFE) Vs The Rest Of The Branded Pharmaceuticals Stocks

Yahoo Finance·Apr 9

This story is reported by Yahoo Finance. Read what other outlets are saying below, then open the original report for full details.

Full coverage

Branded Pharmaceuticals Stocks Q1 Results: Benchmarking Merck (NYSE:MRK)

Yahoo Finance·4d ago

Pfizer vs Merck: Chasing High Yield vs Higher Returns

24/7 Wall St.·Jun 3

Pfizer: Messy Q4 Earnings Mask An Improving Business (NYSE:PFE)

Seeking Alpha·Feb 3

Pfizer (NYSE:PFE) Posts Better-Than-Expected Sales In Q4 CY2025

The Globe and Mail·Feb 3

Spotting Winners: Pfizer (NYSE:PFE) And Branded Pharmaceuticals Stocks In Q1

Yahoo Finance·May 25

Why Pfizer’s Current Price May Be Too Cheap to Ignore

24/7 Wall St.·Jun 2

Pfizer Stock: Cheap For A Reason (NYSE:PFE)

Seeking Alpha·Mar 11

Income Investors Face a Hard Truth About Pfizer’s Payout Safety

24/7 Wall St.·Mar 26

View original report at Yahoo Finance ↗